The inhibition of myeloperoxidase, a pro-inflammatory enzyme mainly secreted by myeloid cells after stroke in the central nervous system, decreases the inflammatory progress in the brain and improves clinical outcome, as found by John Chen and his colleagues in animal models [38]. This evidence concerns the gene MPO and stroke disorder.